• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VENTANA MEDICAL SYSTEMS INC VENTANA PD-L1 (SP142) ASSAY; PROGRAMMED DEATH-LIGAND 1 (PD-L1) IVD, ANTIBODY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VENTANA MEDICAL SYSTEMS INC VENTANA PD-L1 (SP142) ASSAY; PROGRAMMED DEATH-LIGAND 1 (PD-L1) IVD, ANTIBODY Back to Search Results
Catalog Number 08008540001
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/21/2021
Event Type  malfunction  
Event Description
A customer from the united kingdom alleged discrepant results with two patient samples using the ventana pd-l1 (sp142) assay.The alleged samples initially generated a negative result which was reported to medical personnel treating the patient.The samples were then retested using the same assay and generated a positive result.
 
Manufacturer Narrative
The material number is not marketed or distributed in the us.However, roche observed unacceptable, light staining with some ventana pd-l1 (sp142) on-market lots, during internal comparison studies.Light staining affects the borderline of positive versus negative test results.An on-going investigation has determined the root cause is related to variability in the selection of antibody concentration in raw materials, affecting specific ventana pd-l1 (sp142) assay lots made with the impacted raw materials.A notification has been sent to us customers informing them of the issue to immediately discontinue the use of and discard any remaining inventory of specific impacted lots and informing of an updated date of expiration for certain lots.The alleged samples were initially tested on 21 jan 2021 using lot g16831 and on 09 aug 2021 using lot g25464, respectively.The repeat run dates are unknown.To date, no harm is alleged.G16831 expiration date = 06/17/2022 g24564 expiration date = 09/13/2022 e1 facility name truncated due to character limit: (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENTANA PD-L1 (SP142) ASSAY
Type of Device
PROGRAMMED DEATH-LIGAND 1 (PD-L1) IVD, ANTIBODY
Manufacturer (Section D)
VENTANA MEDICAL SYSTEMS INC
1910 e innovation park dr
tucson AZ 85755
Manufacturer (Section G)
VENTANA MEDICAL SYSTEMS INC
1910 e innovation park dr
na
tucson AZ 85755
Manufacturer Contact
timothy blair
1080 us hwy 202 s
building 500, room: 3530
branchburg, NJ 08876
9253534412
MDR Report Key17397557
MDR Text Key319779993
Report Number2028492-2023-00033
Device Sequence Number1
Product Code PLS
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P160002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Remedial Action Recall
Type of Report Initial
Report Date 07/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/17/2022
Device Catalogue Number08008540001
Device Lot NumberG16831,G24564
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/06/2023
Initial Date FDA Received07/26/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberZ-0907-2023 RES91199
Patient Sequence Number1
-
-